Financial Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets byTim AllenOctober 27, 2025
Biologics Sports Medicine Organogenesis Provides Update on Second Phase 3 ReNu® Study byTim AllenSeptember 26, 2025
Financial BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update byTim AllenAugust 12, 2025
Financial BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update byTim AllenMay 14, 2025
Financial Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives byTim AllenMarch 31, 2025
Financial Regulatory Spine Top Stories SPINEWAY: Update on the legal proceedings against Strategos byJosh SandbergMarch 21, 2025
Spine Top Stories Aclarion Provides Corporate Update on Nociscan AI Technology Milestones byJosh SandbergSeptember 12, 2024
Biologics Financial Spine Top Stories Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer byJosh SandbergJanuary 8, 2024
Financial Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility byJosh SandbergNovember 7, 2023
Extremities Regulatory Bioretec postpones Annual General Meeting to a later date byJosh SandbergMarch 17, 2023
